Jubilant Clinsys Inc. has experience in study design, statistical planning, operational strategies and study conduct for pharmaceutical and device interventions in cardiovascular disease. We have conducted studies for marketed drugs and devices intended for expanded labeling, additional safety assessment, and fulfillment of post-marketing commitments to regulatory agencies. To gain access to the right patients, we have established strong relationships with experienced investigators (cardiologists, interventional cardiologists, endocrinologists, hospitalists/internists, and general practitioners) at study sites including academic institutions, specialty clinics, and community-based clinics.
Cardiovascular Disease Indication Experience
Interventional Cardiology Device Experience
Over the past five years, Jubilant Clinsys has been involved in almost 40 studies in multiple cardiovascular indications, including consulting and Phase I through Phase IV studies.